Table 1. Prostacyclin Receptor Agonist Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Prostacyclin Receptor Agonist Market Restraints

Table 3. Prostacyclin Receptor Agonist Market Trends

Table 4. Prostacyclin Receptor Agonist Industry Policy

Table 5. Global Prostacyclin Receptor Agonist Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Prostacyclin Receptor Agonist Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Prostacyclin Receptor Agonist Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 8. Global Prostacyclin Receptor Agonist Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 9. Global Prostacyclin Receptor Agonist Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)

Table 10. Global Prostacyclin Receptor Agonist Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Prostacyclin Receptor Agonist Mergers & Acquisitions, Expansion Plans

Table 12. Global Prostacyclin Receptor Agonist Manufacturers Product Type

Table 13. Head Office and Prostacyclin Receptor Agonist Production Site of Key Manufacturer

Table 14. Prostacyclin Receptor Agonist Capacity of Major Manufacturers and Future Plan

Table 15. China Prostacyclin Receptor Agonist Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 16. China Prostacyclin Receptor Agonist Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 17. China Prostacyclin Receptor Agonist Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 18. Global Prostacyclin Receptor Agonist Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 19. Global Prostacyclin Receptor Agonist Production by Region, 2018-2023, (K Units)

Table 20. Global Prostacyclin Receptor Agonist Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of Prostacyclin Receptor Agonist Upstream (Raw Materials)

Table 22. Global Prostacyclin Receptor Agonist Typical Customers

Table 23. Prostacyclin Receptor Agonist Typical Distributors

Table 24. By Type, Global Prostacyclin Receptor Agonist Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 25. By Application, Global Prostacyclin Receptor Agonist Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 26. By Region, Global Prostacyclin Receptor Agonist Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 27. By Region, Global Prostacyclin Receptor Agonist Consumption Value, 2018-2029, US$ Million

Table 28. By Region, Global Prostacyclin Receptor Agonist Sales Quantity, 2018-2029, (K Units)

Table 29. By Country, Global Prostacyclin Receptor Agonist Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Country, Global Prostacyclin Receptor Agonist Consumption Value, 2018-2029, US$ Million

Table 31. By Country, Global Prostacyclin Receptor Agonist Consumption Value Market Share, 2018-2029

Table 32. By Country, Global Prostacyclin Receptor Agonist Sales Quantity, 2018-2029, (K Units)

Table 33. By Country, Global Prostacyclin Receptor Agonist Sales Quantity Market Share, 2018-2029

Table 34. United Therapeutics Corporation Company Information, Head Office, Market Area, and Industry Position

Table 35. United Therapeutics Corporation Prostacyclin Receptor Agonist Models, Specifications, and Application

Table 36. United Therapeutics Corporation Prostacyclin Receptor Agonist Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 37. United Therapeutics Corporation Company Profile and Main Business

Table 38. United Therapeutics Corporation Recent Developments

Table 39. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 40. Pfizer Prostacyclin Receptor Agonist Models, Specifications, and Application

Table 41. Pfizer Prostacyclin Receptor Agonist Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Pfizer Company Profile and Main Business

Table 43. Pfizer Recent Developments

Table 44. Insmed Incorporated Company Information, Head Office, Market Area, and Industry Position

Table 45. Insmed Incorporated Prostacyclin Receptor Agonist Models, Specifications, and Application

Table 46. Insmed Incorporated Prostacyclin Receptor Agonist Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Insmed Incorporated Company Profile and Main Business

Table 48. Insmed Incorporated Recent Developments

Table 49. Gilead Sciences Company Information, Head Office, Market Area, and Industry Position

Table 50. Gilead Sciences Prostacyclin Receptor Agonist Models, Specifications, and Application

Table 51. Gilead Sciences Prostacyclin Receptor Agonist Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Gilead Sciences Company Profile and Main Business

Table 53. Gilead Sciences Recent Developments

Table 54. CRISPR Therapeutics Company Information, Head Office, Market Area, and Industry Position

Table 55. CRISPR Therapeutics Prostacyclin Receptor Agonist Models, Specifications, and Application

Table 56. CRISPR Therapeutics Prostacyclin Receptor Agonist Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. CRISPR Therapeutics Company Profile and Main Business

Table 58. CRISPR Therapeutics Recent Developments

Table 59. Chiesi Farmaceutici Company Information, Head Office, Market Area, and Industry Position

Table 60. Chiesi Farmaceutici Prostacyclin Receptor Agonist Models, Specifications, and Application

Table 61. Chiesi Farmaceutici Prostacyclin Receptor Agonist Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Chiesi Farmaceutici Company Profile and Main Business

Table 63. Chiesi Farmaceutici Recent Developments

Table 64. Bayer AG Company Information, Head Office, Market Area, and Industry Position

Table 65. Bayer AG Prostacyclin Receptor Agonist Models, Specifications, and Application

Table 66. Bayer AG Prostacyclin Receptor Agonist Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Bayer AG Company Profile and Main Business

Table 68. Bayer AG Recent Developments

Table 69. Arena Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 70. Arena Pharmaceuticals Prostacyclin Receptor Agonist Models, Specifications, and Application

Table 71. Arena Pharmaceuticals Prostacyclin Receptor Agonist Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Arena Pharmaceuticals Company Profile and Main Business

Table 73. Arena Pharmaceuticals Recent Developments

Table 74. Actelion Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 75. Actelion Pharmaceuticals Prostacyclin Receptor Agonist Models, Specifications, and Application

Table 76. Actelion Pharmaceuticals Prostacyclin Receptor Agonist Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Actelion Pharmaceuticals Company Profile and Main Business

Table 78. Actelion Pharmaceuticals Recent Developments

List of Figures

Figure 1. Prostacyclin Receptor Agonist Picture

Figure 2. Global Prostacyclin Receptor Agonist Consumption Value, (US$ million) & (2018-2029)

Figure 3. Global Prostacyclin Receptor Agonist Sales Quantity, (K Units) & (2018-2029)

Figure 4. Global Prostacyclin Receptor Agonist Average Selling Price (ASP), (2018-2029) & (US$/Unit)

Figure 5. China Prostacyclin Receptor Agonist Consumption Value, (US$ million) & (2018-2029)

Figure 6. China Prostacyclin Receptor Agonist Sales Quantity (K Units) & (2018-2029)

Figure 7. China Prostacyclin Receptor Agonist Average Selling Price (ASP), (US$/Unit) & (2018-2029)

Figure 8. By Consumption Value, China Prostacyclin Receptor Agonist Market Share of Global, 2018-2029

Figure 9. By Sales Quantity, China Prostacyclin Receptor Agonist Market Share of Global, 2018-2029

Figure 10. Global Prostacyclin Receptor Agonist Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Prostacyclin Receptor Agonist Key Participants, Market Share, 2022

Figure 12. Global Prostacyclin Receptor Agonist Capacity, Production and Capacity Utilization, 2018-2029

Figure 13. Global Prostacyclin Receptor Agonist Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Prostacyclin Receptor Agonist Production Market Share & Forecast by Region, 2018-2029

Figure 15. Prostacyclin Receptor Agonist Industry Chain

Figure 16. Prostacyclin Receptor Agonist Procurement Model

Figure 17. Prostacyclin Receptor Agonist Sales Model

Figure 18. Prostacyclin Receptor Agonist Sales Channels, Direct Sales, and Distribution

Figure 19. Epoprostenol Sodium

Figure 20. Treprostinil

Figure 21. Beraprost

Figure 22. By Type, Global Prostacyclin Receptor Agonist Consumption Value, 2018-2029, US$ Million

Figure 23. By Type, Global Prostacyclin Receptor Agonist Consumption Value Market Share, 2018-2029

Figure 24. By Type, Global Prostacyclin Receptor Agonist Sales Quantity, 2018-2029, (K Units)

Figure 25. By Type, Global Prostacyclin Receptor Agonist Sales Quantity Market Share, 2018-2029

Figure 26. By Type, Global Prostacyclin Receptor Agonist Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 27. Hospital

Figure 28. Pharmaceutical Company

Figure 29. Laboratory

Figure 30. Clinic

Figure 31. Others

Figure 32. By Application, Global Prostacyclin Receptor Agonist Consumption Value, 2018-2029, US$ Million

Figure 33. By Application, Global Prostacyclin Receptor Agonist Consumption Value Market Share, 2018-2029

Figure 34. By Application, Global Prostacyclin Receptor Agonist Sales Quantity, 2018-2029, (K Units)

Figure 35. By Application, Global Prostacyclin Receptor Agonist Sales Quantity Market Share, 2018-2029

Figure 36. By Application, Global Prostacyclin Receptor Agonist Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 37. By Region, Global Prostacyclin Receptor Agonist Consumption Value Market Share, 2018-2029

Figure 38. By Region, Global Prostacyclin Receptor Agonist Sales Quantity Market Share, 2018-2029

Figure 39. North America Prostacyclin Receptor Agonist Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 40. By Country, North America Prostacyclin Receptor Agonist Consumption Value Market Share, 2022

Figure 41. Europe Prostacyclin Receptor Agonist Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 42. By Country, Europe Prostacyclin Receptor Agonist Consumption Value Market Share, 2022

Figure 43. Asia Pacific Prostacyclin Receptor Agonist Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 44. By Country/Region, Asia Pacific Prostacyclin Receptor Agonist Consumption Value Market Share, 2022

Figure 45. South America Prostacyclin Receptor Agonist Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 46. By Country, South America Prostacyclin Receptor Agonist Consumption Value Market Share, 2022

Figure 47. Middle East & Africa Prostacyclin Receptor Agonist Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 48. U.S. Prostacyclin Receptor Agonist Sales Quantity, 2018-2029, (K Units)

Figure 49. By Type, U.S. Prostacyclin Receptor Agonist Sales Quantity Market Share, 2022 VS 2029

Figure 50. By Application, U.S. Prostacyclin Receptor Agonist Sales Quantity Market Share, 2022 VS 2029

Figure 51. Europe Prostacyclin Receptor Agonist Sales Quantity, 2018-2029, (K Units)

Figure 52. By Type, Europe Prostacyclin Receptor Agonist Sales Quantity Market Share, 2022 VS 2029

Figure 53. By Application, Europe Prostacyclin Receptor Agonist Sales Quantity Market Share, 2022 VS 2029

Figure 54. China Prostacyclin Receptor Agonist Sales Quantity, 2018-2029, (K Units)

Figure 55. By Type, China Prostacyclin Receptor Agonist Sales Quantity Market Share, 2022 VS 2029

Figure 56. By Application, China Prostacyclin Receptor Agonist Sales Quantity Market Share, 2022 VS 2029

Figure 57. Japan Prostacyclin Receptor Agonist Sales Quantity, 2018-2029, (K Units)

Figure 58. By Type, Japan Prostacyclin Receptor Agonist Sales Quantity Market Share, 2022 VS 2029

Figure 59. By Application, Japan Prostacyclin Receptor Agonist Sales Quantity Market Share, 2022 VS 2029

Figure 60. South Korea Prostacyclin Receptor Agonist Sales Quantity, 2018-2029, (K Units)

Figure 61. By Type, South Korea Prostacyclin Receptor Agonist Sales Quantity Market Share, 2022 VS 2029

Figure 62. By Application, South Korea Prostacyclin Receptor Agonist Sales Quantity Market Share, 2022 VS 2029

Figure 63. Southeast Asia Prostacyclin Receptor Agonist Sales Quantity, 2018-2029, (K Units)

Figure 64. By Type, Southeast Asia Prostacyclin Receptor Agonist Sales Quantity Market Share, 2022 VS 2029

Figure 65. By Application, Southeast Asia Prostacyclin Receptor Agonist Sales Quantity Market Share, 2022 VS 2029

Figure 66. India Prostacyclin Receptor Agonist Sales Quantity, 2018-2029, (K Units)

Figure 67. By Type, India Prostacyclin Receptor Agonist Sales Quantity Market Share, 2022 VS 2029

Figure 68. By Application, India Prostacyclin Receptor Agonist Sales Quantity Market Share, 2022 VS 2029

Figure 69. Middle East & Africa Prostacyclin Receptor Agonist Sales Quantity, 2018-2029, (K Units)

Figure 70. By Type, Middle East & Africa Prostacyclin Receptor Agonist Sales Quantity Market Share, 2022 VS 2029

Figure 71. By Application, Middle East & Africa Prostacyclin Receptor Agonist Sales Quantity Market Share, 2022 VS 2029

Figure 72. Research Methodology

Figure 73. Breakdown of Primary Interviews

Figure 74. Bottom-up and Top-down Approaches

Figure 75. Top-down Approaches